World's Best Scientists 2026 revealed!
Mirella Giovarelli

Mirella Giovarelli

D-Index & Metrics

Immunology

D-Index
57
Citations
9837
World Ranking
3644
National Ranking
148

Overview

Mirella Giovarelli is affiliated with the University of Turin in Italy. Their research primarily spans the fields of Medicine, Immunology and Microbiology, and Biochemistry, Genetics and Molecular Biology. Within these fields, their work extends into several subfields, including Immunology, Molecular Biology, Pulmonary and Respiratory Medicine, Biomedical Engineering, and Surgery.

The scholar has contributed to topics such as Immunotherapy and Immune Responses, Nanoplatforms for cancer theranostics, Prostate Cancer Treatment and Research, RNA Interference and Gene Delivery, Prostate Cancer Diagnosis and Treatment, Bladder and Urothelial Cancer Treatments, and Trace Elements in Health.

Frequent coauthors collaborating with Mirella Giovarelli include Sergio Occhipinti, Francesco Novelli, Monica Argenziano, Anna Scomparin, and Costanza Angelini. Their publications have appeared in various venues, with notable frequency in the journals Cancers, Drug Delivery and Translational Research, Annals of Medicine, and Research Square.

Their recent papers include:

  • Exploring chitosan-shelled nanobubbles to improve HER2+ immunotherapy via dendritic cell targeting, 2022, Drug Delivery and Translational Research
  • Low Levels of Urinary PSA Better Identify Prostate Cancer Patients, 2021, Cancers
  • Urinary Zinc Loss Identifies Prostate Cancer Patients, 2022, Cancers
  • Macrophages expressing TREM-1 are involved in the progression of HPV16-related oropharyngeal squamous cell carcinoma, 2021, Annals of Medicine
  • Exploring Chitosan-Shelled Nanobubbles to Improve HER2+ Immunotherapy Through Dendritic Cells Targeting, 2021, Research Square

Best Publications

  • Constitutive activation of NF‐κB and T‐cell leukemia/lymphoma in Notch3 transgenic mice

    Diana Bellavia;Antonio F. Campese;Edoardo Alesse;Alessandra Vacca

  • DNA Vaccination Against Rat Her-2/Neu p185 More Effectively Inhibits Carcinogenesis Than Transplantable Carcinomas in Transgenic BALB/c Mice

    Stefania Rovero;Augusto Amici;Emma Di Carlo;Roberto Bei

  • Interleukin 12–mediated Prevention of Spontaneous Mammary Adenocarcinomas in Two Lines of Her-2/neu Transgenic Mice

    Katia Boggio;Giordano Nicoletti;Emma Di Carlo;Federica Cavallo

  • Human Monocytes Constitutively Express Membrane-Bound, Biologically Active, and Interferon-γ–Upregulated Interleukin-15

    Tiziana Musso;Liliana Calosso;Mario Zucca;Maura Millesimo

  • Regulation of Human Macrophage M1-M2 Polarization Balance by Hypoxia and the Triggering Receptor Expressed on Myeloid Cells-1.

    Federica Raggi;Simone Pelassa;Daniele Pierobon;Federica Penco

  • Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with interleukin (IL)-2, IL-4, IL-6, IL-7, IL-10, tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, and gamma-interferon gene or admixed with conventional adjuvants.

    Alessandra Allione;Manuela Consalvo;Patrizia Nanni;Pier Luigi Lollini

  • Role of neutrophils and CD4+ T lymphocytes in the primary and memory response to nonimmunogenic murine mammary adenocarcinoma made immunogenic by IL-2 gene.

    Federica Cavallo;Mirella Giovarelli;Alberto Gulino;Alessandra Vacca

  • Local release of IL-10 by transfected mouse mammary adenocarcinoma cells does not suppress but enhances antitumor reaction and elicits a strong cytotoxic lymphocyte and antibody-dependent immune memory.

    M Giovarelli;P Musiani;A Modesti;P Dellabona

  • Treatment of recurrent squamous cell carcinoma of the head and neck with low doses of lnterleukin‐2 injected periiymphatically

    Giorgio Cortesina;Antonella de Stefani;Mirella Giovarelli;Maria Grazia Barioglio

  • CYTOKINES, TUMOUR-CELL DEATH AND IMMUNOGENICITY : A QUESTION OF CHOICE

    Piero Musiani;Andrea Modesti;Mirella Giovarelli;Federica Cavallo

  • Monocytes and dendritic cells in a hypoxic environment : Spotlights on chemotaxis and migration

    Maria Carla Bosco;Maura Puppo;Fabiola Blengio;Tiziana Fraone

  • Antitumor efficacy of adenocarcinoma cells engineered to produce interleukin 12 (IL-12) or other cytokines compared with exogenous IL-12.

    Federica Cavallo;Paola Signorelli;Mirella Giovarelli;Piero Musiani

  • Lactoferrin, a major defense protein of innate immunity, is a novel maturation factor for human dendritic cells

    Michela Spadaro;Cristiana Caorsi;Patrizia Ceruti;Atul Varadhachary

  • Human mesenchymal stem cells and derived extracellular vesicles induce regulatory dendritic cells in type 1 diabetic patients

    Enrica Favaro;Andrea Carpanetto;Cristiana Caorsi;Mirella Giovarelli

  • An efficient Th2-type memory follows CD8+ lymphocyte-driven and eosinophil-mediated rejection of a spontaneous mouse mammary adenocarcinoma engineered to release IL-4.

    F Pericle;M Giovarelli;M P Colombo;G Ferrari

  • Vaccination With ENO1 DNA Prolongs Survival of Genetically Engineered Mice With Pancreatic Cancer

    Paola Cappello;Simona Rolla;Roberto Chiarle;Moitza Principe

  • Lymphokine-activated tumor inhibition in vivo. I. The local administration of interleukin 2 triggers nonreactive lymphocytes from tumor-bearing mice to inhibit tumor growth.

    G Forni;M Giovarelli;A Santoni

  • Human mesenchymal stem cell-derived microvesicles modulate T cell response to islet antigen glutamic acid decarboxylase in patients with type 1 diabetes

    Enrica Favaro;Andrea Carpanetto;Sara Lamorte;Alberto Fusco

  • An integrated humoral and cellular response is elicited in pancreatic cancer by alpha-enolase, a novel pancreatic ductal adenocarcinoma-associated antigen.

    Paola Cappello;Barbara Tomaino;Roberto Chiarle;Patrizia Ceruti

  • Tumor rejection and immune memory elicited by locally released LEC chemokine are associated with an impressive recruitment of APCs, lymphocytes, and granulocytes.

    Mirella Giovarelli;Paola Cappello;Guido Forni;Theodora Salcedo

  • Hypoxia modulates the gene expression profile of immunoregulatory receptors in human mature dendritic cells: identification of TREM-1 as a novel hypoxic marker in vitro and in vivo.

    Maria Carla Bosco;Daniele Pierobon;Fabiola Blengio;Federica Raggi

  • in vitro and in vivo

    Gabriella Regis;Marita Bosticardo;Laura Conti;Stefania De Angelis

Frequent Co-Authors

Guido Forni
Guido Forni University of Turin
Francesco Novelli
Francesco Novelli University of Turin
Federica Cavallo
Federica Cavallo University of Turin
Santo Landolfo
Santo Landolfo University of Turin
Andrea Modesti
Andrea Modesti University of Rome Tor Vergata
Piero Musiani
Piero Musiani University of Chieti-Pescara
Angela Santoni
Angela Santoni Sapienza University of Rome
Luigi Varesio
Luigi Varesio MRC Laboratory of Molecular Biology
Roberto Chiarle
Roberto Chiarle Harvard University
Patrizia Nanni
Patrizia Nanni University of Bologna

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can open diverse career opportunities. Many students transition into nursing roles to complement their scientific expertise. If you’re a non-nurse looking to quickly enter the nursing field, several online ABSN programs for non nurses offer accelerated paths to becoming a registered nurse.

Finding the right program nearby is crucial for balancing study and life commitments. Resources listing the accelerated nursing programs near me can help you identify flexible and fast-track options that suit your schedule.

For those considering practical nursing, it’s important to understand which programs align with career goals and acceptance criteria. Knowing which LPN programs are easiest to get into can simplify the application process and allow quicker entry into healthcare settings.

Furthermore, advanced practice roles like nurse practitioners require specialized training. Exploring which nurse practitioner program is easiest can provide options that balance rigor and accessibility, enhancing your prospects in clinical or research-driven environments.

Best Scientists Citing Mirella Giovarelli

Trending Scientists